BIOABioAge Labs, Inc.
$6.35+30% 1Y
$6.35
$4.9452 weeks$24.29
The financials
BioAge Labs, Inc. by the numbers
BioAge Labs, Inc. (BIOA) reported revenue of $2.5M in Q2 2026 (quarter ended Jun 30, 2026), up 1.6% from the same quarter a year earlier. That came with net loss of $26M. For the full year FY2025, revenue was $9.0M and net income −$81M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.5M | $2.4M | +1.6% |
| Operating income | −$29M | −$25M | n/a |
| Net income | −$26M | −$22M | n/a |
| Diluted EPS | −$0.58 | −$0.60 | n/a |
On our screens:Stocks with no debt
Drug Manufacturers, Specialty & Generic
The closest names by size in the same industry